(2,3-Difluoro-4-methoxyphenyl)boronic acid, 95.0%, 5g

1,2-Bis(difluoromethoxy)benzene, 97.0%, 1g

2-(2-Bromoethyl)pyridine hydrobromide, 98.0%, 1g

Ditetradecyl 3,3'-Thiodipropionate>98.0%(qNMR)500g

2,5-Dimethyl-4-nitrophenol, 95.0%, 10g

1-(4-fluorophenyl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one, 95.0%, 2.5g

Tris(2-benzimidazolylmethyl)amine, 95%, 1g

Di-potassium hydrogen phosphate, min. 98%, Ph.Eur., anhydrous, 500 g, plastic packaging.

2-(3-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetic acid, 97%, 1g

tert-Butyl 4-(5-fluoro-2-methylbenzylamino)piperidine-1-carboxylate, 1g

6-Bromo-8-fluoroquinolin-2(1H)-one, 97%, 250mg

boc-b-Homoisoleucine, 95.0%, 100mg

butyl[(2-fluorophenyl)methyl]amine hydrochloride, 95.0%, 1g